Want to join the conversation?
Latham, New York-based $ANGO said in 4Q16 the company successfully launched the new Asclera varicose and spider vein treatments and benefited from additional volume as a result of the Cook Medical recall. Growth in the Oncology/Surgery International business was driven by the approval of NanoKnife Probes in China.
$MON shares dip slightly; I wonder this is because of the environmental lawsuit filed by the Washington state against the production of PCBs.
My bet is that $FR will reach $32 in the short term. It’s time it broke the 52-week high and had its fair share of growth.
$WYNN got bruised up by China after its decision to cut withdrawal limit in Macau ATMs. Wynn Resorts shares went down by more than 11%! Well who could have guessed that right?